throbber
' 1993 Nature Publishing Group http://www.nature.com/naturegenetics
`
`review
`
`The rapid detection of unknown
`mutations in nucleic acids
`
`Markus Grompe
`
`The task of identifying mutations in nucleic acid sequences is a vital component of
`research in mammalian genetics. With the advent of the polymerase chain reaction,
`several useful mutation detection techniques have evolved in recent years. The different
`methods have complementing strengths and a suitable procedure for virtually any
`experimental situation is now available.
`
`Department of
`Molecular and
`Medical Genetics
`and Department of
`Pediatrics, Oregon
`Health Sciences
`University, 3181
`SW Sam Jackson
`Park Road,
`Portland, Oregon
`97201, USA
`
`Techniques for the detection of naturally occurring
`mutations that disrupt genes are of use to biologists in
`many fields. Inhuman genetics, these methods are used to
`determine whether a candidate gene is causally related to
`a phenotype and also to identify new alleles at known loci
`for diagnostic, population genetics and structure/function
`studies. Procedures for mutation detection can be
`separated into two distinct groups. The first consists of
`techniques which efflcientlyidentify known disease alleles,
`such as population screening for carriers of the common
`cystic fibrosis (CF) mutations’, 1. The second group consists
`of methods to scan sequences for unknown mutations
`and will be the subject of this review. While several useful
`technologies for the detection of sequence heterogeneity
`exist, no single method is applicable for all situations. The
`most appropriate screening technology is influenced by
`the expected nature of the mutation, size and structure of
`the locus in question, availability of mRNA, degree of
`sensitivity required and resources available.
`The spectrum of mutations ranges from cytogenetically
`visible chromosome rearrangements to micro-deletions
`and insertions and finally single base alterations. Some
`loci, such as the steroid suiphatase gene 3, are very prone to
`deletions, whereas others, such as the CF gene 4, are
`associated with hundreds of point mutations. Candidate
`loci can be as complex in structure as the dystrophin gene,
`with a 14 kilobase (kb) peptide coding region and 80
`exons5 or as simple as the SRY (male sex determination)
`locus with only one large exon6. In recessive autosomal
`and X-linked diseases the use of mRNA enables larger
`stretches of coding sequence to be examined together.
`Many genes of interest, however, may not be expressed in
`easily accessible samples such as blood or fibroblasts,
`nature genetics volume 5 october 1993 (cid:9)
`
`leaving analysis of genomic DNA as the only option.
`Finally, automation and fluorescence detection technology
`have many advantages, but the high cost limits their
`availability.
`
`Detection of large gene alterations
`Large gene alterations can be contrasted to single base
`changes and are mutations in which substantial portions
`(>500 basepairs (bp)) of a gene are deleted, duplicated or
`otherwise rearranged.
`
`Cytogenetic techniques
`Extremely large (> 1 megabase (Mb)) deletions and
`insertions can be detected by high resolution cytogenetics 7 .
`Recently, the power of cytogenetic analysis has been
`enhanced by the use of fluorescent in situ hybridization
`(FISH) 89. FISH uses fluorescently labelled DNA probes,
`which are hybridized to chromosome spreads, to detect
`not only the presence or absence of a chromosomal region
`corresponding to the probe, but also its position in the
`genome. Multiple probes labeled with different fluorescent
`dyes can be hybridized and analyzed simultaneously.
`FISH is particularly suited for the detection ofaneuploidy,
`micro-deletions or duplications and complex
`rearrangements, and has found awide range ofapplications
`ranging from the detection of loss of heterozygosity in
`tumour samples", microdeletion syndromes’ or
`duplications".
`
`Southern blot hybridization
`The Southern blot 13 remains one of the fastest methods to
`screen quickly for mutations, and offers a good first step
`in mutation analysis. The main advantage ofthe technique
`111
`
`GeneDX 1008, pg. 1
`
`(cid:9)
`

`

`review
`
`ey ' 1993 Nature Publishing Group http://www.nature.com/naturegenetics
`
`
`
`mutant DNA
`
`b (cid:9)
`
`2 3 4 5 (cid:9)
`
`a
`wild-type DNA
`
`*
`*
`
`denature (cid:9)
`
`single-stranded j
`confirmation
`
`- *
`
`*
`
`differential migration -I
`of single strands in a
`non-denaturing gel
`
`Wt (cid:9)
`
`In
`
`is that no detailed knowledge of the structure and sequence
`of a gene is required and a preliminary screen can be
`carried out with a probe of interest immediately after its
`isolation. Large deletions and insertions may be detected
`by the presence ofj unction fragments or changes in band
`intensities in blots (assuming equal amounts of DNA are
`present in all lanes). Point mutations may also be
`detectable, if they alter restriction sites. The restriction
`endonucleases MspI and TaqI have 4 base recognition
`sites (CCGG and TCGA respectively) that contain the
`mutation-prone dinucleotide CpG 14. These enzymes are
`therefore especially useful in scanning for mutations by
`Southern blot.
`
`PCR-based detection methods
`The ability to amplify DNA enzymatically via the
`polymerase chain reaction" represents the most important
`advance in mutation detection technology since the
`development ofDNA sequencing’ 6"7. All of the procedures
`described below rely on PCR amplification of sample
`DNA prior to analysis.
`
`Multiplex PCR for the detection of deletions
`Ifa locus ofinterest is prone to deletions and if its genomic
`sequences are known, the simultaneous PCR amplification
`of several sequences throughout the gene (multiplex
`amplification) is the most rapid and practical method for
`their detection. Deletions are indicated by the absence of
`some of the bands in the multiplex pattern. This method
`has found wide use in the diagnosis of Duchenne muscular
`dystrophy’s, in which 60% of cases represent deletions",
`
`112 (cid:9)
`
`Fig. 1 The principal of SSG analysis. a,
`Schematic representation. Wild-type
`(wt) and mutant (m) PCR products are
`shown at the top. The presence of a
`point mutation is represented by a dot
`on the DNA strands. Different single-
`stranded conformation lead to
`differential mobility in the gel. b, SSC
`analysis of exon 4 of the ornithine
`aminotransferase gene. Lanes 1 and
`5, normal controls: lanes 2-4,
`demonstrate band shifts indicating the
`presence of mutations.
`
`MONO (cid:9)
`
`WN (cid:9)
`
`but has been employed for other disorders" ,". In
`heterozygotes, deletions are seen as 50% reductions of
`band intensities in a quantitative analysis of the multiplex
`PCR reaction 22.
`The simultaneous amplification of several sequences of
`interest can also be useful in the search for single-base
`alterations (see below).
`
`Detection of single base changes
`Single-base alterations are the most common type of
`mutation at most loci. A number of methods may be used
`for detecting these subtle changes.
`
`Single-stranded conformational (SSC) analysis
`In 1989, Orita et al. first reported the use of single-
`stranded conformational polymorphisms (SSCP) to
`detect mutations". SSC analysis has since become the
`most widely used of the scanning technologies. Wild-
`type and mutant target DNA are amplified by PCR,
`denatured and then electrophoresed side by side through
`a (usually glycerol containing) non-denaturing
`polyacrylamide gel. The two single-stranded DNA
`molecules from each denatured PCR product assume a
`three-dimensional conformation which is dependent on
`the primary sequence. Ifa sequence difference (mutation)
`exists between wild-type and mutant DNA, this may
`result in differential migration of one or both of the
`mutant strands (Fig. I). PCR products with altered
`migration patterns can then be analysed by DNA
`sequencing to determine the exact nature of the alteration.
`The main advantage of SSC analysis is its simplicity and
`relative sensitivity. No additional steps are required after
`PCR and the gel system is relatively straightforward. The
`method also lends itself to the simultaneous examination
`of multiple samples. In most published studies the
`amplification products are rendered radioactive by the
`addition of 32P or 35S labelled dCTP to the PCR reaction.
`However, non-radioactive detection by silver-staining 24
`and ethidium bromide staining 11 have been successfully
`used. SSC analysis detects mutations but does not localize
`them within the fragment.
`SSC analysis detects 70-95% of mutations in PCR
`products of 200 bp or less 26’27. The sensitivity of the
`method decreases with the size of the PCR product and is
`less than 50% when fragments of >400 bp are analysed.
`Some of the size limitations of the method may be
`overcome by the simultaneous amplification and analysis
`of several fragments in one lane (multiplexing) or by
`restriction digestion of a larger amplification product
`prior to electrophoresis". The use of RNA generated by in
`
`nature genetics volume 5 october 1993
`
`GeneDX 1008, pg. 2
`
`

`

`' 1993 Nature Publishing Group http://www.nature.com/naturegenetics
`
`
`
`review
`
`vitrotranscription of PCRproducts also appears to improve
`detection of mutations in larger fragments 29 .
`
`Denaturing gradient gel electrophoresis (DGGE)
`DGGE also relies on differential electrophoretic migration
`of wild-type and mutant DNA for the detection of
`mutations. Double-stranded DNA (dsDNA) generated
`by PCR is electrophoresed through agradient ofincreasing
`concentration ofa denaturing agent (urea andformamide).
`As the DNA migrates, the strands progressively dissociate
`in discrete sequence-dependent domains of low melting
`temperature. This partial "melting" ofthe dsDNA leads to
`an abrupt decrease of mobility (Fig. 2). DNA molecules
`differing by only a single base substitution have been
`shown to exhibit differential mobility in such gels". The
`sensitivity of DGGE is greatly enhanced, however, if
`heteroduplex DNA between wild-type and mutant
`sequences is used for the analysis". Mutations can be
`found most reliably when the sequence heterogeneity lies
`within a domain of relatively low melting temperature.
`This can be achieved for virtually any sequence of interest
`by the use of computer programs to predict theoretical
`melting profiles and design PCRprimers". The attachment
`of a (30-50 bp) high melting temperature GC-clamp""
`to one PCR primer is critical to ensure that the amplified
`
`wild-type DNA
`
`mutant DNA
`
`denature and mix
`
`tero- and
`homoduplex DNA
`
`I (cid:9)
`
`electrophoresis in
`denaturing gradient
`
`differential
`melting behaviour
`
`low denaturant
`
`Wt wt+m
`= =
`
`- (cid:151)
`
`high denaturant
`
`Fig. 2 The principal of DGGE. Wild-type (wt) and mutant
`(m) PCR products are denatured and reannealed to
`generate 4 species of hetero- and homoduplexes.
`Differential melting behavior leads to altered migration in a
`gradient of denaturing agents compared to wild-type
`homoduplex.
`nature geneiws volume 5 october 1993 (cid:9)
`
`sequence has a low dissociation temperature.
`Once the appropriate PCR primers and denaturant
`conditions have been developed for a specific region,
`DGGE is a highly reliable and rapid method for mutation
`detection. Single base differences can be detected with
`(cid:150)95% accuracy in PCR products of up to 600 bp in length.
`Detection is usually carried out by non-radioactive
`means""’. As in SSC analysis, while the presence of a
`sequence difference is detected, its location within the
`fragment remains unknown and has to be determined by
`sequencing.
`The denaturing gradient can also be generated by
`temperature and this method is termed temperature
`gradient gel electrophoresis (TGGE)".
`
`Heteroduplex analysis (HA)
`If mutant and wild-type template sequences are present
`simultaneously in a PCR reaction, heteroduplexes between
`the two different DNA species can be formed during the
`late cycles. Heteroduplex molecules with a single bp
`variance may show differential mobility from
`homoduplexes in regular polyacrylamide gels’. This
`phenomenon is thought to be caused by sequence
`dependent conformational changes in the dsDNA.
`Recently, new gel matrices (Hydrolinkfiand MDETm from
`AT Biochem) have become available which markedly
`enhance the ability to detect mutation induced mobility
`shifts in heteroduplex molecules. These gel matrices are
`poured between glass-plates, analogous to polyacrylamide
`gels used for DNA sequencing. Mutant and wild-type
`PCR products are electrophoresed side by side and their
`mobility compared. Recent studies indicate a level of
`sensitivity similar to SSC analysis (80-90%) in small DNA
`fragments (<300 bp) 19 ’40. Both isotopic’ and non-isotopic’ 9
`detection methods have been reported. This technique is
`attractive because of its simplicity and has been applied
`successfully to the study of a number of human genetic
`disorders"".
`
`RNase A cleavage
`The principal of heteroduplex mismatch analysis
`applicable to both RNase and chemical mismatch cleavage
`(see below) is illustrated in Fig. 3. In RNase A cleavage, an
`RNA-DNA heteroduplexbetween a radioactive wild-type
`riboprobe and mutant DNA, generated by PCR, is
`subjected to cleavage by RNase A
`6. This enzyme will
`recognize and cleave single-stranded RNA at the points of
`mismatch. The reaction is analysed by electrophoresis
`and autoradiography. The presence and location of a
`mutation are indicated by a cleavage band of a given size.
`This method is limited by the need for radioactively
`labelled RNA and the fact that RNase A can only detect
`(cid:150)50% of mismatches. Ithas therefore been largely replaced
`by the similar technique chemical mismatch cleavage.
`
`Chemical mismatch cleavage (CIVIC)
`In CMC, a heteroduplex between a radiolabeled wild-
`type DNA molecule and mutant DNA (or RNA) is created
`by boiling and reannealing. Maxam-Gilbert sequencing
`chemistry ’ 7 is then used to chemically modify mismatched
`bases at the sites of mutations in the DNA(cid:150)DNA or DNA(cid:150)
`RNA heteroduplexes. The labelled DNA is cleaved by
`piperidine at the site of the modification, and this is
`followed by denaturing PAGE and autoradiography 47 .
`Osmium tetroxide is used for the modification ofmispaired
`
`113
`
`GeneDX 1008, pg. 3
`
`(cid:9)
`

`

`' 1993 Nature Publishing Group http://www.nature.com/naturegenetics
`
`
`
`review (cid:9)
`
`a
`
`9’
`
`heteroduplex between
`labeled wt and (cid:9)
`labeled mutant strand
`
`________
`
`mismatch
`
`electrophoresis
`detects cleaved
`fragment
`wild-type (cid:9) mutant
`
`chemical modification of
`mismatched bases by
`bydroxylamine or
`osmium tetroxide
`HA (cid:9)
`Oso-
`
`/
`mutation (mismatch)
`
`id
`
`piperidine cleaves
`modified mismatches
`
`(cid:151)
`
`(cid:9) - (cid:9)
`
`full length probe
`
`cleavage product
`
`mismatch
`
`4 (cid:9)
`___ (cid:9)
`
`5 (cid:9)
`
`6 (cid:9)
`
`7 (cid:9)
`
`8
`
`~40 4W
`
`b (cid:9)
`
`1 (cid:9)
`
`2 (cid:9)
`
`3 (cid:9)
`
`1196 - (cid:151)
`1025 -
`975 -
`
`775 -
`
`6W -
`
`445 -
`
`Fig. 3 The
`principal of
`heteroduplex
`mismatch
`cleavage, a,
`Schematic
`representation of
`chemical
`mismatch
`cleavage. A
`heteroduplex
`between labelled
`wild-type DNA
`(top strand) and
`unlabelled
`mutant DNA is
`shown. The
`mismatched
`base at the site
`of the mutation is
`chemically
`modified and
`subsequently
`cleaved by
`pipendine. b, 0MG analysis of the human omithine transcarbamylase cDNA 70.
`Cleavage products indicating the presence of mutations can be seen in all lanes
`except lane 4, which represents a normal control.
`
`Table I Advantages and disadvantages of mutation scanning methods
`
`Size Sensitivity Localizes
`
`Toxic
`chemicals
`
`Exon
`mRNA
`scanning scanning
`
`Best
`ref.
`
`250
`SSCP
`600
`DGGE
`1700
`0MG
`PGR DS 500
`300
`HA
`
`80% (cid:9)
`95% (cid:9)
`>95% (cid:9)
`>99% (cid:9)
`80% (cid:9)
`
`no
`no
`yes
`yes
`no
`
`none
`formamide
`yes
`none
`none
`
`.i-++
`++
`+
`++
`++
`
`+
`++
`+++
`++
`+
`
`26
`67
`68
`69
`40
`
`The size of fragments which can be analysed is given in bp. Sensitivity, the
`approximate % of mutations detectable with the method is given; localizes,
`indicates whether a method provides the exact location of the mutation within
`the examined fragment; +++, indicates a high, ++ moderate and + limited
`usefulness of the method for this application.
`
`114 (cid:9)
`
`thymines and hydroxylamine for mismatched cytosines.
`Adenosine and guanosine mismatches of the wild-type
`sense strand are detected by also labelling the anti-sense
`strand of wild-type DNA in the heteroduplex. CMC is
`very sersitive, detecting >95% of mismatches when only
`the wil4-type DNA is labelled and 100%, when both wild-
`type and mutant DNA are labelled. CMC has the lowest
`size constraint of all the mutation scanning methods.
`PCR products of up to 1.7 kb in length have been examined
`successfully49, permitting efficient screening of amplified
`mRNAs. As well as detecting the sequence alteration
`reliably, the precise localization and nature of the change
`is also indicated by the size of the cleavage band and the
`cleaving reagent. Non-isotopic labelling techniques’ and
`multiplexing" have been reported for this technique.
`A highly sensitive variation of CIVIC has been described
`by Ganguly and Prockopt 2. Chemical modification of the
`mismatched base(s) is carried Out with carbodiimide
`(CDI), and this is followed by primer extension using a
`radiolabeled oligonucleotide. Taq polymerase terminates
`extension at modified bases and the shortened extension
`product is detected byautoradiograpby. This method has
`been applied primarily for the detection of mutations in
`collagen genes.
`
`Direct sequencing
`All the methods described above are capable of detecting
`mutations with varying efficiencies, but none defines
`preciselythe nature ofthe change. DNA sequencing defines
`the location and nature of the a change and therefore is a
`necessary final step of any mutation detection method. If
`DNA sequencing can be made rapid, accurate and efficient,
`it represents the ideal mutation "scanning" technique.
`Direct sequencing (DS) refers to the direct sequence
`analysis of PCR products without prior subcloning into
`sequencing vectors and can be the primary method of
`mutation detection. As this methodbecomes more efficient
`with the use of automation and new fluorescence detection
`technology, it is likely to become the primary method of
`mutation detection. Direct sequencing is based on the
`Sanger dideoxy chain termination method’ 6, and both
`isotopic as well as fluorescence detection techniques have
`been described. Fluorescence based sequencing methods
`have many advantages, but require expensive specialized
`equipment.
`In order to sequence PCR products successfully by the
`conventional dideoxy termination protocol, it is essential
`to convert the double-stranded PCR product into a single-
`stranded sequencing template. Several methods have been
`described to achieve this. In the first technique, termed
`asymmetric PCR53, the PCR product is reamplified in a
`second reaction in which one of the oligonucleotide
`primers is in >100:1 excess of the other. This creates an
`abundance of single-stranded PCR product for sequencing.
`In the second method one of the PCR primers is
`biotinylated. After the reaction, the double-stranded PCR
`product is captured on an avidin-coated magnetic bead" ’64.
`The non-biotinylated strand is melted away with NaOH
`and the sequencing reactions are carried out on the
`immobilized single-stranded template. Inathird approach,
`termed "genomic amplification with transcript
`sequencing" (GAWTS) the original PCRprimers carry T7
`RNA polymerase binding sites". In vitro transcription is
`then used to generate single-stranded RNA template for
`sequencing.
`
`nature genelzcs volume 5 october 1993
`
`GeneDX 1008, pg. 4
`
`(cid:9)
`

`

`' 1993 Nature Publishing Group http://www.nature.com/naturegenetics
`
`
`
`review
`
`techniques over the past few years has been rapid, and new
`and promising advances are being tested in many
`laboratories. Three of these new methods will be
`mentioned here. The first is termed dideoxy fingerprinting
`(ddF). ddF represents a combination of SSC analysis and
`direct sequencing". After amplification, the PCR product
`is sequenced with dideoxyCTP (ddCTP) to generate a "C-
`ladder" (fingerprint) of bands. The sequencing reactions
`from wild-type and mutant samples are then
`electrophoresed through a SSC (non-denaturing
`polyacrylamide) gel. Mutations are detectable as shifts of
`individual bands inthe ladder. This method, when applied
`to the factor IX gene, was highly sensitive (84/84 alleles
`detected) and also provided some information about the
`localization of the sequence alteration.
`The second new technique utilizes a computer software
`variation in the analysis of fluorescent cycle sequencing
`data60. Fluorescent sequencing is carried out in routine
`fashion, and all 4 termination reactions are loaded into a
`single gel lane. A set of 4 adjacent lanes is then used for the
`parallel analysis of the sequence ladder generated by a
`single dideoxy terminator (single color analysis). This
`permits the detection of additional peaks which indicate
`mutations. Extra peaks are detectable if up to 4 individual
`sequencing reactions are loaded into a single lane, thus
`permitting the simultaneous analysis of 16 samples. This
`method appears especially useful when high throughput
`automated sequencing is available.
`Recently, E. coli mismatch repair enzymes have been
`used for the detection ofknown mutations in oncogenes 61 .
`If these enzymes are able to detect mismatches in larger
`heteroduplex molecules containing unknown mutations,
`they may find wide application in mutation detection.
`
`r fT (cid:9)
`L (cid:9)
`.cj (cid:9)
`
`fli (cid:9)
`
`" fl (cid:9)
`
`fl (cid:9)
`
`r
`
`( (cid:9) (cid:149)1 (cid:9)
`i.i (cid:9)
`U (cid:9)
`L (cid:9)
`11 C)
`r (cid:9)
`
`(
`L
`
`r
`
`Fig. 4 Direct sequencing with fluorescent primers. A
`portion of the human CD4 genomic locus was sequenced.
`In the position marked by an N, a G and I peak appear in
`the same position indicating a sequence alteration on one
`chromosome.
`
`A recent promising modification of dideoxy chain
`termination sequencing technology is cycle sequencing,
`also termed amplification sequencing’"’. In this method,
`the template is simultaneously amplified and sequenced
`by the addition of dideoxy terminators to a PCR reaction.
`This technique has the advantage of requiring onlyminute
`amounts of template. When isotopic detection methods
`or conventional fluorescence sequencing protocols are
`used, however, cycle sequencing requires that the
`sequencing primer be end-labeled (either by an isotope or
`by a fluorochrome). Recently, a new protocol based on
`cycle sequencing and fluorescence detection technology
`has been developed 58. Fluorescently labeled dideoxy
`terminators (dye terminators) are used with a different
`fluorescent dye coupled to each of the four ddNTPs. The
`extension product is labelled at the site of the dideoxy
`termination rather than at the sequencing primer end. In
`this direct sequencing protocol, neither specially modified
`PCR or sequencing primers are needed.
`An example of a result obtained by fluorescent
`technology direct sequencing is shown in Fig. 4.
`
`Future methods
`The pace of improvements in mutation detection
`
`Mutation versus polymorphism
`The methods described above will detect nucleic acids
`alterations but do not necessarily define their biological
`significance. Some sequence changes, such as those causing
`frame-shifts or chain terminations, are obviously
`functionally deleterious to a protein. Other alterations,
`such as missense mutations leading to amino acid
`substitutions or base changes in introns and untranslated
`regions, can be either functionally relevant or represent
`sequence polymorphisms. Additional information
`including family studies, population
`studies or functional assays after in
`vitro expression may be needed to
`Table 2 Genomic DNA versus mRNA as starting material for mutation analysis
`determine the significance of a
`… sequence alteration.
`
`Genomic DNA
`
`mRN
`
`Advantages (cid:9)
`
`Easily accessible (blood)
`In autosomal loci both alleles
`are equally represented
`Mutations in the promoter and
`intronic splice junctions can be
`detected
`First choice in autosomal
`dominant traits
`
`Disadvantages Genomic sequence and gene structure
`information are needed
`Only small segments of coding region
`(exons) are analysed
`More PCR reactions
`
`nauregenehco volume 5 october 1993 (cid:9)
`
`Long segments of peptide coding
`region can be analysed
`Gene structure information not
`needed
`Fewer PCR reactions
`Aberrant mRNA sizes can be seen
`First choice in X-linked traits
`
`Gene may not be expressed in
`accessible specimens
`In autosomal loci only one allele
`may be represented
`Mutations in the promoter and
`intronic splice junctions are not
`detected
`
`Comparison of methods
`The relative usefulness of the
`techniques mentioned above for the
`detection of single base alterations
`depends upon a number of criteria.
`Table 1 summarizes the advantages
`and disadvantages of the different
`procedures. Obviously, the level of
`expertise for a certain procedure, and
`the equipment available, are other
`determining factors.
`
`Size factors: mutant mRNA
`versus genomic DNA
`The two principal materials on which
`
`115
`
`GeneDX 1008, pg. 5
`
`

`

`review (cid:9)
`
`' 1993 Nature Publishing Group http://www.nature.com/naturegenetics
`
`mutation analysis can be carried out are the mRNA and
`genomic DNA. Several considerations are important in
`deciding which material to use for mutation detection
`(Table 2). If mRNA is readily available (from cultured
`cells or pathological specimens), it is usually the most
`practicalstarting material because larger stretches ofcoding
`sequence can be scanned. The use of specialized PCR
`protocols may permit the amplification of mRNA from
`tissues in which the gene is expressed at only very low
`levels (illegitimate transcription)62’ 63(cid:149) The mode of
`inheritance of a phenotype for which mutations are being
`sought also has an impact on the choice ofstarting material.
`mRNA analysis is less desirable for dominant conditions,
`because the mutant allele may not be represented in
`mRNA (null alleles).
`In mRNA analysis, reverse transcription is used to
`generate first strand cDNA, and this is followed by PCR
`amplification to generate large (1-2 kb) fragments from
`cDNAM. When genomic DNA is used, smaller segments
`of coding sequence (exons) usually are amplified. The
`different mutation detection techniques are not equally
`useful for both approaches. SSC and HA are particularly
`advantageous for the study of small DNA fragments
`(<300 bp), notably in the exon analysis of genomic DNA.
`Direct sequencing and DGGE are sensitive up to 500-600
`bp, and CMC can be used for fragments up to 1700 bp.
`The methods capable of scanning large segments of
`DNA are also useful in the study of organisms with few
`introns such as bacteria and viruses 6
`
`.
`
`Sensitivity and accuracy
`As mentioned above, the sensitivity of the different
`mutation detection procedures is dependent on the size of
`the fragment to be analysed. Even when scanning small
`DNA fragments, however, SSC analysis and HA are not as
`sensitive as DGGE, CMC and direct sequencing.
`Sequencing and CMC are the onlymethods that accurately
`localize the mutation within the examined fragment.
`
`Candidate gene versus known defective gene
`If a gene is known to be defective (in a patient with a
`genetic disease), the requirements in mutation analysis
`are different than when a gene is a candidate, but not
`already known to carry a mutation. Known defective
`
`genes are often examined in a diagnostic setting, in
`which a high degree of accuracy is needed. Frequently
`the same locus is analysed repetitively in large numbers
`of patients or in populations for carrier detection. In
`these situations, it may become practical to design
`specialized oligonucleotides for direct sequencing
`(biotinylated or fluorescent) or DGGE (GC-clamps).
`Direct sequencing and DGGE are more sensitive than
`SSC analysis or heteroduplex analysis and are therefore
`frequently used in this setting, even for the testing of
`small DNA fragments. The specialized set-up required is
`worthwhile because of the large sample numbers and
`because of the degree of accuracy required. This is in
`contrast to a candidate gene analysis, in which any given
`locus may or may not have mutations. Specialized
`reagents and equipment are less practical in this scenario,
`and it is less critical to detect 100% of mutations, if
`enough patient samples are available. Often details of the
`structure of the candidate locus are not known and
`examination of mRNA (only coding sequence needed) is
`desirable. In this context, the size of the sequence to be
`examined usually determines the method of choice (see
`above).
`
`Radioactivity and toxicity
`In all procedures described, the detection methodology
`can be either radioactive or non-radioactive. SSC, DGGE
`and heteroduplex analysis can be easily carried out non-
`isotopically with simple ethidium bromide staining of
`DNA. This is less simple for CMC and direct sequencing,
`for which fluorescence detection is needed. Of all the
`techniques, CMC clearly has the most problems with the
`use of toxic chemicals. Both osmium tetroxide and
`piperidine are highly noxious and not suitable for use in
`a clinical laboratory environment.
`
`Simplicity and speed
`SSCP, HA and DGGE (once set up) are clear front runners
`for simplicity, in that the analysis of the PCR product can
`be carried out immediately after the reaction. CMC and
`sequencing both require several manipulations after PCR
`and are more time-consuming. Automation and dye
`terminator cycle-sequencing, however, are making direct
`sequencing a very rapid approach.
`
`116 (cid:9)
`
`naturegeneflcc volume october1993
`
`GeneDX 1008, pg. 6
`
`

`

`' 1993 Nature Publishing Group http://www.nature.com/naturegenetics
`
`
`
`review
`
`I would like to
`thank R.A. Gibbs
`for providing Figure
`4 and for his critical
`review of the
`manuscript. Figure
`lb was used with
`the kind permission
`of D. Valle.
`
`rain.
`
`1. Ghettab, F.F. & Wail, J. Detection of multiple cystic fibrosis mutations by
`reveraedot blot hybridization: atectrnoiogyforcanier screwing. Hum. Garret.
`89,163--168 (1992).
`2. Ng, I$. etal. Methods for analysis of multiple cystic fibrosis mutations. Hum.
`Garret. 87, 813-617 (1991),
`3. Ballablo, A. of at Molecular heterogeneity of steroid sulfatase deficiency: a
`multicenter study on 57 unrelated patients, at DNA and protein lassie.
`Genom/cs 4, 36-40 (1989).
`4. Tsui, L.C.Thespectrumotoyatic fibrosis mutations. Trends Genet. 8,392-398
`(1992).
`5. Koenig, M., Monaco, A.P.&Kunkel, L.M.Thecompletesequenceofdystrophln
`predicts a rod-shaped cytosiceletal protein. Cell 53,219-226(1988).
`6. Sinclair, A.H.etal. A gene from the human sex-determining region encodes a
`protein with homology to a conserved DNA-binding motif. Nature 348,240-
`244 (1990).
`7. Rooney, D.E.&Czepxilkowsk B.H. Human cytogerietics:apractica’approach
`RL Press, Oxford, New York, 1992).
`6. Zhang, P.R., 1-leilig, ft. Thomas, G. & Aurias, A. A one-step efficient and
`specific non-radioactive non-fluorescent method for in situ hybridization of
`banded chromosomes. Chromosome 99,436-439(1990).
`9. Bsum,ann, H., Chrif, D. & Berger, R. Interphase cytogenetics by fluorescent
`In situ hybridization (FISH) for characterization of monosorny-7-associated
`myeloid disorders, Leukemia 7, 384-391 (1993).
`10. Taylor, C. atal. Diagnosis of Ewing’ssarcomaand penpheralneciroectoderrnal
`tumour based on the detection of 1(1 122) using fluorescence in situ
`hybridization. Br. J. Cancer 67, 128-133 (1993).
`11, Kuwano, A., Ledbetter, S.A., Dobyns, W.B., Emanuel, B.S. & Ledbetter, D.H.
`Detection of deletions and cryptic trarrslocations in Miller-Dlekersyndrome by
`In situ hybridization. Am. J. hum. Garret. 49, 707-714 (1991).
`12. Lupsis, J.R. at at DNA duplication associated with Charcot-Marie-Tooth
`disease type 1A. Cell. 66,219-232(1991).
`13. Southern, E.M. Detection of specific sequences among DNA fragments
`separated by gel electrophoresis. J. mo/ac. Biol. 98,503-517 (1 975).
`14. Cooper, D.N. & Youssoufian, H. The GPO dinucleotide and human genetic
`disease. Hum. Garret. 78,151-155 (1988).
`15. Mullis, KB.&Faioona, F.A.Specific synthesisof DNA in vitrovias polymerase-
`Catalyzed chain reaction. Math. Ertzymol. 155,335-350(1987).
`16. Sanger, F., Mcklen,S.&Couleon,A,R. DhtA

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket